1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Partnerships for Indigenous-led ELSI Research (PIER) is sponsored by National Human Genome Research Institute (NIH). This grant supports tribally-led genomic research aimed at addressing American Indian and Alaska Native (AI/AN) health disparities.
The initiative focuses on strengthening meaningful collaboration with AI/AN communities and AI/AN-serving health systems in Alaska and Oklahoma to promote Indigenous-driven approaches to genomic research. It also includes a Community Scholars program to support researchers interested in Tribal health research.
Get alerted about grants like this
Get emailed when new opportunities from “National Human Genome Research Institute (NIH)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Universities, in collaboration with Tribal healthcare organizations and AI/AN communities, are eligible. The project is led by Southcentral Foundation with the University of Oklahoma as a key collaborator. Confirm the full requirements in the official notice before applying.
The current listing shows $1,553,238. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Applications for Partnerships for Indigenous-led ELSI Research (PIER) are due June 1, 2027. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Partnerships for Indigenous-led ELSI Research (PIER) is funded by National Human Genome Research Institute (NIH). Verify program details on the funder's official page before applying.
This opportunity targets applicants in Oklahoma. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward advances in AI and data science for biomedical and public health research. Projects must cross disciplinary boundaries.
The Complement-ARIE program funds seven technology centers to develop human-based models that complement animal research. What it means for drug developers, academic researchers, and the regulatory pipeline.
Read articleNIH launched Complement-ARIE with $150M to develop organ-on-chip, AI models, and other NAMs that simulate human biology. What biotech researchers and grant seekers need to know.
Read articleAs of October 1, 2025, NIH no longer posts Notices of Funding Opportunity in the NIH Guide — Grants.gov is now the single official source (NOT-OD-25-143). The weekly Guide table-of-contents email that thousands of investigators relied on to discover funding no longer lists opportunities. Combined with the January 25, 2026 SciENcv certified-PDF requirement, the mechanics of finding and applying for NIH money have changed underneath everyone. Here is how to rebuild your discovery workflow so nothing slips through.
Read article